Three novel tridentate pyridazine phenolate ligands were prepared in high yields by Schiff-base condensation of salicylic aldehyde with various pyridazine hydrazines (substituent R in the 6 position: R = Cl (HL(Cl)), (t)Bu (HL((t)Bu)), or tol (HL(tol))). They react with [ReOCl(3)(OPPh(3))(SMe(2))] to form rare mononuclear trans-dichloro oxo complexes of general formula [ReOCl(2)(L(R))] with R = tol (1), (t)Bu (2), or Cl (3) as confirmed by single-crystal X-ray diffraction analyses of 1 and 2. They were found to be catalysts for oxidation of cyclooctene to the corresponding epoxide by tert-butyl hydroperoxide (TBHP). Extensive UV-vis and NMR spectroscopic investigations followed by evaluation using the powerful Mauser method revealed mechanistic details. This showed the catalyst precursor [ReOCl(2)(L)] (2) to be transformed into the rhenium(VII) compound [ReO(3)L] (4) in a two-step reaction via intermediate INT which is tentatively assigned to [ReO(2)L]. Confirmation gave the isolation of 4 by reaction of 2 with excess of TBHP. Monitoring the catalytic oxidation reaction by UV-vis spectroscopy clearly excludes the two rhenium(V) compounds 2 and INT from being the catalytically active species as their formation is several orders of magnitude faster than the observed catalytic epoxidation reaction.
No takes yet. Share an insight, caveat, or question.
Grunwald et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: